Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New heart mapping device could make arrhythmia treatments more precise

NCT ID NCT02647749

First seen May 16, 2026 · Last updated Jun 23, 2026 · Updated 8 times

Summary

This study tested a non-invasive mapping system (Cardioinsight®) to help doctors treat heart rhythm disorders. It included 492 patients who needed ablation, pacemaker implantation, or risk assessment for sudden death. The goal was to see if the mapping system improves outcomes compared to standard methods without mapping.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC RHYTHM DISORDERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU de Bordeaux

    Bordeaux, 33000, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Cardioinsight® mapping system (device)

What this could lead to

If successful, this could make heart rhythm procedures more precise and reduce the need for repeat treatments.

What could go wrong

This is a completed care protocol, not a randomized trial, so results may be less definitive. The device may not work for all types of arrhythmias.

Conditions

The condition(s) this trial relates to.

cardiac rhythm disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.